ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 61 filers reported holding ONCOCYTE CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $144,000 | -38.7% | 160,238 | +1.4% | 0.02% | -31.2% |
| Q1 2022 | $235,000 | -57.0% | 158,004 | -37.4% | 0.03% | -53.6% |
| Q4 2021 | $547,000 | +153.2% | 252,298 | +570.3% | 0.07% | +187.5% |
| Q2 2021 | $216,000 | -6.9% | 37,641 | -15.7% | 0.02% | -36.8% |
| Q1 2021 | $232,000 | -43.0% | 44,626 | -73.8% | 0.04% | -43.3% |
| Q4 2020 | $407,000 | +45.9% | 170,146 | -15.4% | 0.07% | +42.6% |
| Q3 2020 | $279,000 | – | 201,047 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,093,219 | $6,833,000 | 1.15% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| CITIGROUP INC | 642 | $4,000 | 0.00% |
| Sonora Investment Management, LLC | 50 | $0 | 0.00% |
| BARCLAYS PLC | 206 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 96 | $1,000 | 0.00% |